1-methyl-3-isobutylxanthine and urotensin i

1-methyl-3-isobutylxanthine has been researched along with urotensin i in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bern, HA; Marshall, WS1
Abou-Samra, AB; Assil, IQ1
Facci, L; Franceschini, D; Pangallo, M; Skaper, SD; Stevens, DA; Strijbos, PJ1

Other Studies

3 other study(ies) available for 1-methyl-3-isobutylxanthine and urotensin i

ArticleYear
Active chloride transport by the skin of a marine teleost is stimulated by urotensin I and inhibited by urotensin II.
    General and comparative endocrinology, 1981, Volume: 43, Issue:4

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Biological Transport, Active; Chlorides; Epinephrine; Fishes; Kinetics; Peptides; Skin; Urotensins

1981
N-glycosylation of CRF receptor type 1 is important for its ligand-specific interaction.
    American journal of physiology. Endocrinology and metabolism, 2001, Volume: 281, Issue:5

    Topics: 1-Methyl-3-isobutylxanthine; Amphibian Proteins; Animals; Binding Sites; Binding, Competitive; Cell Line; Consensus Sequence; Corticotropin-Releasing Hormone; Cyclic AMP; Electrophoresis, Polyacrylamide Gel; Glycosylation; Ligands; Mice; Molecular Weight; Mutagenesis, Site-Directed; Peptide Hormones; Peptides; Radioligand Assay; Receptors, Corticotropin-Releasing Hormone; Structure-Activity Relationship; Tunicamycin; Urotensins

2001
Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors.
    Neuropharmacology, 2003, Volume: 45, Issue:5

    Topics: 1-Methyl-3-isobutylxanthine; Amphibian Proteins; Amyloid beta-Peptides; Animals; Animals, Newborn; Apoptosis; Blotting, Western; Cell Survival; Cells, Cultured; Cerebellum; Cerebral Cortex; Chromatin; Chromones; Colforsin; Corticotropin-Releasing Hormone; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Glycogen Synthase Kinase 3; Hippocampus; In Situ Nick-End Labeling; Inhibitory Concentration 50; L-Lactate Dehydrogenase; Mitogen-Activated Protein Kinase Kinases; Morpholines; Neurons; Neuroprotective Agents; Peptide Fragments; Peptide Hormones; Peptides; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Thionucleotides; Time Factors; Urocortins; Urotensins; Vasodilator Agents

2003